Practice Areas
Barrister specialising in intellectual property law, with a particular emphasis on technically complex patent cases in biotechnology and pharmaceuticals. Scheduled trials include Merck v Halozyme (enzymes to improve subcutaneous administration). Recent cases include Accord v Hoffmann-La Roche (subcutaneous formulation; settled after trial), Samsung BioEpis v Alexion (antibody engineering), DSM v Mara (algal fatty acids), Abbott v Dexcom - Trial C (continuous glucose monitors), Gilead v NuCana (nucleoside derivatives), InterDigital v Lenovo (telecoms), Optis v Apple (telecoms), Insulet v Roche (insulin pumps), Royalty Pharma v Boehringer Ingelheim (royalty dispute under German law), GSK v Fibrogen (iron deficiency drugs; settled shortly before trial), Conversant v Huawei (telecoms), Illumina v Ariosa (cell-free foetal DNA enrichment), Silence v Alnylam (RNAi; settled shortly before trial), Pacific Biosciences v Oxford Nanopore (DNA sequencing; settled shortly before trial), Illumina v Premaitha (prenatal diagnosis), Regeneron v Kymab (antibody engineering).
Career
Educated at Trinity College, Cambridge (top 1st in genetics; PhD in molecular biology); City University (distinction in postgraduate diploma in law); BPP (outstanding in bar vocational course). Called 2005, Lincoln's Inn.
